Compare AU

Compare CURE vs. VSO

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the Vanguard MSCI Australian Small Companies Index ETF (VSO). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

VSO

Popularity

Low

Low

Pearlers invested

83

229

Median incremental investment

$619.50

$999.87

Median investment frequency

Monthly

Monthly

Median total investment

$1,455.16

$2,249.60

Average age group

> 35

> 35


Key Summary

CURE

VSO

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

VSO.AX was created on 2011-05-23 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. Vanguard MSCI Australian Small Companies Index ETF seeks to track the return of the MSCI Australian Shares Small Cap Index before taking into account fees, expenses and tax.

Top 3 holdings

Natera Inc (3.33 %)

Incyte Corp (2.96 %)

Gilead Sciences Inc (2.80 %)

carsales.com Ltd. (2.47 %)

Atlas Arteria Ltd. (2.42 %)

Allkem Ltd. (2.38 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Materials (24.32 %)

Industrials (14.76 %)

Financials (12.31 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Australia (98.99 %)

China (0.62 %)

United States (0.26 %)

Management fee

0.45 %

0.3 %


Key Summary

CURE

VSO

Issuer

Global X

Vanguard

Tracking index

S&P Biotechnology Select Industry

MSCI Australian Shares Small Cap Index - AUD

Asset class

ETF

ETF

Management fee

0.45 %

0.3 %

Price

$51.97

$70.73

Size

$36.301 million

N/A

10Y return

N/A

66.89 %

Annual distribution yield (5Y)

4.24 %

5.28 %

Market

ASX

ASX

First listed date

12/11/2018

26/05/2011

Purchase fee

$6.50

$6.50


Community Stats

CURE

VSO

Popularity

Low

Low

Pearlers invested

83

229

Median incremental investment

$619.50

$999.87

Median investment frequency

Monthly

Monthly

Median total investment

$1,455.16

$2,249.60

Average age group

> 35

> 35


Pros and Cons

CURE

VSO

Pros

  • Higher exposure to US market

  • Higher exposure to AU market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to AU market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

  • Lower exposure to US market

CURE

VSO

Lower exposure to AU market

Higher exposure to AU market

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home